VLS Tirzepatide 20mg Pen — Dual Incretin Fat-Loss Peptide

VLS Tirzepatide 20mg Pen featuring dual GIP and GLP-1 receptor activation for advanced fat-loss research.

Concentration & Quality

• 20 mg Tirzepatide per pen
• Prefilled, ready-to-use research formulation
• Vitality Life Science manufacturing standards

Key Features

• Dual incretin pathway activation (GLP-1 + GIP)
• Potent appetite suppression and metabolic support
• High bioavailability in pen form

How to Use

Prefilled pen. Store refrigerated (2–8 °C). For research purposes only.

How It Works

Tirzepatide simultaneously stimulates GLP-1 and GIP receptors, enhancing insulin sensitivity and energy expenditure while reducing appetite for effective fat-loss research.

Storage & Handling

Keep refrigerated at 2–8 °C. Avoid freezing. Protect from light.